RU2016114098A - Новое производное аналога инсулина - Google Patents
Новое производное аналога инсулина Download PDFInfo
- Publication number
- RU2016114098A RU2016114098A RU2016114098A RU2016114098A RU2016114098A RU 2016114098 A RU2016114098 A RU 2016114098A RU 2016114098 A RU2016114098 A RU 2016114098A RU 2016114098 A RU2016114098 A RU 2016114098A RU 2016114098 A RU2016114098 A RU 2016114098A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- administered
- diabetes
- compound according
- same patient
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 206010012601 diabetes mellitus Diseases 0.000 claims 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 3
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (12)
1. А14Е,В16Е,В25Н,В29К(N(эпс)-эйкозандиоил-gGlu-2хОЕG), дезВ30 человеческий инсулин (Соединение 1).
2. Соединение по п. 1 для применения в качестве лекарственного средства.
3. Соединение по п. 1 для применения в качестве лекарственного средства для лечения диабета.
4. Соединение по п. 1 для применения при лечении диабета, где соединение вводят одному и тому же пациенту каждый 2 день или менее часто, и в среднем в течение периода времени, составляющего по меньшей мере 1 месяц, 6 месяцев или 1 год, причем указанное соединение не вводят более часто одному и тому же пациенту.
5. Соединение по п. 1 для применения при лечении диабета, где соединение вводят два раза в неделю или менее часто, и в среднем в течение периода времени, составляющего по меньшей мере 1 месяц, 6 месяцев или 1 год, причем указанное соединение не вводят более часто одному и тому же пациенту.
6. Соединение по п. 1, для применения при лечении диабета, где соединение вводят один раз в неделю или менее часто, и в среднем в течение периода времени, составляющего по меньшей мере 1 месяц, 6 месяцев или 1 год, причем указанное соединение не вводят более часто одному и тому же пациенту.
7. Водный раствор, содержащий соединение по п. 1.
8. Водный раствор по п. 7, содержащий по меньшей мере 5 ионов цинка на гексамер инсулина.
9. Водный раствор по любому из пп. 7-8, имеющий рН в диапазоне от 7 до 8.
10. Фармацевтическая композиция, содержащая соединение по п. 1 и один или более эксципиентов.
11. Фармацевтическая композиция по п. 10, содержащая по меньшей мере 4,5 ионов цинка на гексамер инсулина.
12. Способ лечения или профилактики диабета, включающий введение субъекту, нуждающемуся в этом, терапевтически эффективного количества соединения по п. 1.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13187626 | 2013-10-07 | ||
| EP13187626.0 | 2013-10-07 | ||
| PCT/EP2014/071236 WO2015052088A1 (en) | 2013-10-07 | 2014-10-03 | Novel derivative of an insulin analogue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016114098A true RU2016114098A (ru) | 2017-11-15 |
| RU2016114098A3 RU2016114098A3 (ru) | 2018-05-21 |
| RU2673185C2 RU2673185C2 (ru) | 2018-11-22 |
Family
ID=49301382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016114098A RU2673185C2 (ru) | 2013-10-07 | 2014-10-03 | Новое производное аналога инсулина |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9896496B2 (ru) |
| EP (1) | EP3055325B1 (ru) |
| JP (1) | JP6499184B2 (ru) |
| KR (1) | KR20160065126A (ru) |
| CN (1) | CN105636979B (ru) |
| AU (1) | AU2014333979B2 (ru) |
| BR (1) | BR112016007166A2 (ru) |
| CA (1) | CA2926701A1 (ru) |
| DK (1) | DK3055325T3 (ru) |
| ES (1) | ES2676065T3 (ru) |
| HR (1) | HRP20180468T1 (ru) |
| HU (1) | HUE036702T2 (ru) |
| IL (1) | IL244507B (ru) |
| MX (1) | MX366636B (ru) |
| PL (1) | PL3055325T3 (ru) |
| PT (1) | PT3055325T (ru) |
| RS (1) | RS57004B1 (ru) |
| RU (1) | RU2673185C2 (ru) |
| SA (1) | SA516370893B1 (ru) |
| SI (1) | SI3055325T1 (ru) |
| WO (1) | WO2015052088A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2910570B1 (en) | 2008-03-18 | 2016-10-12 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
| AR105616A1 (es) | 2015-05-07 | 2017-10-25 | Lilly Co Eli | Proteínas de fusión |
| JP7076442B2 (ja) | 2016-11-07 | 2022-05-27 | ノヴォ ノルディスク アー／エス | Ｐｅｇ化合物のｄｃｈｂｓ活性エステル及びその使用 |
| US20180169190A1 (en) | 2016-12-16 | 2018-06-21 | Novo Nordisk A/S | Insulin containing pharmaceutical compositions |
| US11357861B2 (en) | 2017-09-29 | 2022-06-14 | Hanmi Pharm. Co., Ltd | Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor |
| CN111909255A (zh) * | 2019-05-10 | 2020-11-10 | 宁波鲲鹏生物科技有限公司 | 胰岛素衍生物及其制备方法 |
| CA3189527A1 (en) | 2020-07-24 | 2022-01-27 | Jiangsu Gensciences Inc. | Insulin-fc fusion protein and application thereof |
| WO2022247773A1 (en) * | 2021-05-24 | 2022-12-01 | Sunshine Lake Pharma Co., Ltd. | A novel acylated insulin analog |
Family Cites Families (134)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2832685A (en) | 1952-05-24 | 1958-04-29 | Crest Foods Co Inc | Solubilization of milk proteins |
| US3528960A (en) | 1968-10-07 | 1970-09-15 | Lilly Co Eli | N-carboxyaroyl insulins |
| US3719655A (en) | 1969-12-05 | 1973-03-06 | Lilly Co Eli | Process for the crystallization of the ammonium and alkali metal salts in insulin |
| US3950517A (en) | 1970-05-08 | 1976-04-13 | National Research Development Corporation | Insulin derivatives |
| US3869437A (en) | 1970-05-08 | 1975-03-04 | Nat Res Dev | Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4033941A (en) | 1975-12-17 | 1977-07-05 | Eli Lilly And Company | Process for purifying glucagon |
| GB1492997A (en) | 1976-07-21 | 1977-11-23 | Nat Res Dev | Insulin derivatives |
| JPS5767548A (en) | 1980-10-14 | 1982-04-24 | Shionogi & Co Ltd | Insulin analog and its preparation |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| PH23446A (en) | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
| JPH01254699A (ja) | 1988-04-05 | 1989-10-11 | Kodama Kk | インスリン誘導体及びその用途 |
| DK257988D0 (da) | 1988-05-11 | 1988-05-11 | Novo Industri As | Nye peptider |
| AU616205B2 (en) | 1988-07-20 | 1991-10-24 | Novo Nordisk A/S | Human insulin analogs and preparations containing them |
| US5225323A (en) | 1988-11-21 | 1993-07-06 | Baylor College Of Medicine | Human high-affinity neurotransmitter uptake system |
| US5716927A (en) | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
| AU641631B2 (en) | 1988-12-23 | 1993-09-30 | Novo Nordisk A/S | Human insulin analogues |
| DE3844211A1 (de) | 1988-12-29 | 1990-07-05 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| HU210142B (en) | 1989-04-20 | 1995-02-28 | Sinai School Medicine | Process for producing hepatospecific insulin-analogues and pharmaceutical compositions containing them |
| CA1340994C (en) | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| CA2027930C (en) | 1989-10-19 | 1998-06-30 | Tsuyoshi Miyazaki | Polymer complexes of a sugar response type |
| US5179189A (en) | 1990-01-19 | 1993-01-12 | Nova Pharmaceutical Corporation | Fatty acid terminated polyanhydrides |
| DK45590D0 (ru) | 1990-02-21 | 1990-02-21 | Novo Nordisk As | |
| DK155690D0 (da) | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
| DK158390D0 (da) | 1990-07-02 | 1990-07-02 | Novo Nordisk As | Nye peptider |
| WO1992001476A1 (en) | 1990-07-26 | 1992-02-06 | University Of Iowa Research Foundation | Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule |
| DK10191D0 (da) | 1991-01-22 | 1991-01-22 | Novo Nordisk As | Hidtil ukendte peptider |
| US5336782A (en) | 1991-04-24 | 1994-08-09 | Kuraray Co., Ltd. | Long chain carboxylic acid imide ester |
| CA2268476A1 (en) | 1991-07-03 | 1998-04-30 | Hyal Pharmaceutical Corporation | Use of hyaluronan in gene therapy |
| US5268453A (en) | 1991-08-08 | 1993-12-07 | Scios Inc. | Tissue-selective insulin analogs |
| ZA928916B (en) | 1991-11-26 | 1994-05-18 | Lilly Co Eli | Tri-arginine insulins |
| AU5171293A (en) | 1992-10-14 | 1994-05-09 | Regents Of The University Of Colorado, The | Ion-pairing of drugs for improved efficacy and delivery |
| US5359030A (en) | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
| US6869930B1 (en) | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
| NZ273285A (en) * | 1993-09-17 | 1997-10-24 | Novo Nordisk As | Insulin derivatives and compositions thereof |
| GB9323588D0 (en) | 1993-11-16 | 1994-01-05 | Cortecs Ltd | Hydrophobic preparation |
| BR9507023A (pt) | 1994-03-07 | 1997-09-23 | Inhale Therapeutic Syst | Processos para aerossolização de uma dose de insulina para a liberação respiratória de insulina e para preparação de uma composição de insulina e composição de insulina |
| US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| US5646242A (en) | 1994-11-17 | 1997-07-08 | Eli Lilly And Company | Selective acylation of epsilon-amino groups |
| US5693609A (en) | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
| US6251856B1 (en) | 1995-03-17 | 2001-06-26 | Novo Nordisk A/S | Insulin derivatives |
| ATE245659T1 (de) | 1995-03-17 | 2003-08-15 | Novo Nordisk As | Insulinabkömmlinge |
| US5824638A (en) | 1995-05-22 | 1998-10-20 | Shire Laboratories, Inc. | Oral insulin delivery |
| US20030104981A1 (en) | 1995-11-03 | 2003-06-05 | Jelena Mandic | Human insulin analogues |
| US6451970B1 (en) | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
| AU3255397A (en) | 1996-07-05 | 1998-02-02 | Novo Nordisk A/S | Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides |
| AU3255297A (en) | 1996-07-11 | 1998-02-09 | Novo Nordisk A/S | Selective acylation method |
| ATE264871T1 (de) | 1996-07-26 | 2004-05-15 | Aventis Pharma Gmbh | Insulinderivate mit erhöhter zinkbindung |
| US5898067A (en) | 1997-02-07 | 1999-04-27 | Novo Nordisk A/S | Crystallization of proteins |
| US6310038B1 (en) | 1997-03-20 | 2001-10-30 | Novo Nordisk A/S | Pulmonary insulin crystals |
| CA2306905A1 (en) | 1997-10-24 | 1999-05-06 | Eli Lilly And Company | Fatty acid-acylated insulin analogs |
| ATE243711T1 (de) | 1997-10-24 | 2003-07-15 | Novo Nordisk As | Aggregate von menschlichen insulinderivaten |
| ZA989744B (en) | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
| AU1375199A (en) | 1997-11-12 | 1999-05-31 | Alza Corporation | Method for decreasing self-association of polypeptides |
| US6531448B1 (en) | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
| EP1086130A1 (en) | 1998-06-12 | 2001-03-28 | Kings College London | Insulin analogue |
| GB9814172D0 (en) | 1998-06-30 | 1998-08-26 | Andaris Ltd | Formulation for inhalation |
| PT1107743E (pt) | 1998-08-25 | 2007-10-01 | Advanced Inhalation Res Inc | Formulações proteicas estáveis secas por pulverização |
| TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| US7030083B2 (en) | 1998-09-09 | 2006-04-18 | University Of Washington | Treatment of eclampsia and preeclampsia |
| IL142011A0 (en) | 1998-10-16 | 2002-03-10 | Novo Nordisk As | Stable concentrated insulin preparations for pulmonary delivery |
| US6660715B2 (en) | 1998-11-19 | 2003-12-09 | Massachusetts Institute Of Technology | Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
| JP2002535287A (ja) | 1999-01-26 | 2002-10-22 | イーライ・リリー・アンド・カンパニー | 単分散性６量体のアシル化されたインスリンアナログ製剤 |
| WO2000061178A1 (en) | 1999-04-13 | 2000-10-19 | Inhale Therapeutics Systems, Inc. | Pulmonary administration of dry powder formulations for treating infertility |
| AU4450700A (en) | 1999-04-27 | 2000-11-10 | Eli Lilly And Company | Insulin crystals for pulmonary administration |
| WO2000069901A2 (en) | 1999-05-19 | 2000-11-23 | Xencor, Inc. | Proteins with insulin-like activity useful in the treatment of diabetes |
| US6746853B1 (en) | 1999-05-19 | 2004-06-08 | Xencor, Inc. | Proteins with insulin-like activity useful in the treatment of diabetes |
| US6309633B1 (en) | 1999-06-19 | 2001-10-30 | Nobex Corporation | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
| CN1141974C (zh) | 2000-06-07 | 2004-03-17 | 张昊 | 结肠定位释放的口服生物制剂 |
| US6867183B2 (en) | 2001-02-15 | 2005-03-15 | Nobex Corporation | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith |
| CN1160122C (zh) | 2001-04-20 | 2004-08-04 | 清华大学 | 一种制备口服胰岛素油相制剂的方法 |
| AP1763A (en) | 2001-05-21 | 2007-08-02 | Nektar Therapeutics | Pulmonary administration of chemically modified insulin |
| US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| US6858580B2 (en) | 2001-06-04 | 2005-02-22 | Nobex Corporation | Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| JP2004537580A (ja) | 2001-08-10 | 2004-12-16 | エピックス メディカル， インコーポレイテッド | 延長された循環半減期を有するポリペプチド結合体 |
| PE20030536A1 (es) | 2001-09-07 | 2003-07-03 | Biocon Ltd | Metodos para sintetizar conjugados polipeptido de insulina-oligomero, y conjugados polipeptido de proinsulina-oligomero y metodos de sintetizar dichos conjugados |
| US7030082B2 (en) | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
| US6770625B2 (en) | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
| AU2002349295A1 (en) | 2001-12-02 | 2003-06-17 | Novo Nordisk A/S | Glucose dependant release of insulin from glucose sensing insulin derivatives |
| JP2005515197A (ja) | 2001-12-03 | 2005-05-26 | ドー バイオファーマ インコーポレイテッド | 安定化された逆ミセル組成物およびその使用 |
| AU2002314790A1 (en) | 2001-12-05 | 2003-06-23 | Dow Global Technologies Inc. | Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications |
| IL161848A0 (en) | 2001-12-20 | 2005-11-20 | Lilly Co Eli | Insulin moldecule having protracted time action |
| JP2005526126A (ja) | 2002-05-07 | 2005-09-02 | ノボ ノルディスク アクティーゼルスカブ | インスリンアスパルト及びインスリンデテミアを含む可溶性製剤 |
| AU2003236201A1 (en) | 2002-05-07 | 2003-11-11 | Novo Nordisk A/S | Soluble formulations comprising monomeric insulin and acylated insulin |
| US7601688B2 (en) | 2002-06-13 | 2009-10-13 | Biocon Limited | Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus |
| CN1165549C (zh) | 2002-06-15 | 2004-09-08 | 江苏万邦生化医药股份有限公司 | 胰岛素的纯化方法 |
| PL1633391T3 (pl) | 2003-06-03 | 2012-03-30 | Novo Nordisk As | Stabilizowane farmaceutycznie kompozycje peptydowe |
| WO2005005477A2 (en) | 2003-07-11 | 2005-01-20 | Novo Nordisk A/S | Stabilised insulin compositions |
| SI1648933T1 (sl) | 2003-07-25 | 2010-01-29 | Conjuchem Biotechnologies Inc | Dolgo delujoäś inzulinski derivat in metoda zanj |
| EP2107069B1 (en) | 2003-08-05 | 2013-01-16 | Novo Nordisk A/S | Novel insulin derivatives |
| PT1660047E (pt) | 2003-08-13 | 2014-02-27 | Biocon Ltd | Formulação de dosagem sólida de sais de ácidos gordos em micropartículas para agentes terapêuticos |
| AU2004273573B2 (en) * | 2003-09-19 | 2010-04-22 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| JP2007532096A (ja) | 2003-11-14 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | アシル化されたインスリンの製造方法 |
| CN102784386A (zh) | 2003-11-20 | 2012-11-21 | 诺沃挪第克公司 | 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂 |
| WO2005058961A2 (en) | 2003-12-12 | 2005-06-30 | Amgen Inc. | Antibodies specific for human galanin, and uses thereof |
| DE10358387A1 (de) | 2003-12-13 | 2005-07-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung |
| WO2005092301A1 (en) | 2004-03-26 | 2005-10-06 | Universita' Degli Studi Di Parma | Insulin highly respirable microparticles |
| MXPA06012980A (es) | 2004-05-10 | 2007-06-12 | Nastech Pharm Co | Composiciones y metodos para el suministro mucosal mejorado de la hormona paratiroidea. |
| NZ553263A (en) | 2004-07-19 | 2010-06-25 | Biocon Ltd | Insulin-oligomer conjugates, formulations and uses thereof |
| ES2543007T3 (es) | 2004-08-23 | 2015-08-13 | Mannkind Corporation | Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos |
| AU2005311601B2 (en) | 2004-12-03 | 2011-12-01 | Rhode Island Hospital | Diagnosis and treatment of Alzheimer's Disease |
| EP1843790A2 (en) | 2005-01-27 | 2007-10-17 | Novo Nordisk A/S | Insulin derivatives conjugated with structurally well defined branched polymers |
| US8067362B2 (en) | 2005-02-02 | 2011-11-29 | Novo Nordisk As | Insulin derivatives |
| US20080171695A1 (en) | 2005-02-02 | 2008-07-17 | Novo Nordisk A/S | Insulin Derivatives |
| JP2008533100A (ja) | 2005-03-18 | 2008-08-21 | ノボ ノルディスク アクティーゼルスカブ | Ｐｅｇ化された単鎖インスリン |
| WO2007006320A1 (en) | 2005-07-12 | 2007-01-18 | Sherine Hassan Abbas Helmy | Drinkable oral insulin liquid and capsules |
| US20070086952A1 (en) | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
| JP4710533B2 (ja) | 2005-10-07 | 2011-06-29 | 株式会社豊田自動織機 | 牽引車両のドローバー装置 |
| US20100210506A1 (en) | 2005-10-20 | 2010-08-19 | Mdrna, Inc. | Intranasal administration of rapid acting insulin |
| ES2371361T3 (es) | 2005-12-28 | 2011-12-30 | Novo Nordisk A/S | Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones. |
| WO2007081824A2 (en) | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
| JP2009527526A (ja) | 2006-02-21 | 2009-07-30 | ノボ・ノルデイスク・エー／エス | 単鎖インスリンのアナログとその製薬的製剤 |
| US8722620B2 (en) | 2006-02-27 | 2014-05-13 | Novo Nordisk A/S | Insulin derivatives |
| EP1996223A1 (en) | 2006-03-13 | 2008-12-03 | Novo Nordisk A/S | Acylated single chain insulin |
| EP2386572B1 (en) | 2006-05-09 | 2015-07-08 | Novo Nordisk A/S | Insulin derivative |
| EP2024390B1 (en) | 2006-05-09 | 2015-08-19 | Novo Nordisk A/S | Insulin derivative |
| CN101573133B (zh) | 2006-07-31 | 2014-08-27 | 诺沃-诺迪斯克有限公司 | Peg化延长的胰岛素 |
| JP5864834B2 (ja) | 2006-09-22 | 2016-02-17 | ノボ・ノルデイスク・エー／エス | プロテアーゼ耐性のインスリンアナログ |
| US20100120660A1 (en) | 2007-04-30 | 2010-05-13 | Per Balschmidt | Highly concentrated insulin solutions and compositions |
| AU2008257505B2 (en) | 2007-06-01 | 2013-05-16 | Novo Nordisk A/S | Stable non-aqueous pharmaceutical compositions |
| JP5552046B2 (ja) * | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー／エス | インスリン誘導体を含有する薬学的製剤 |
| EP2170945A1 (en) | 2007-07-16 | 2010-04-07 | Novo Nordisk A/S | Protease stabilized, pegylated insulin analogues |
| RU2514430C2 (ru) | 2007-08-15 | 2014-04-27 | Ново Нордиск А/С | Аналоги инсулина с ацильной и алкиленгликолевой группировкой |
| JP5721432B2 (ja) | 2007-08-15 | 2015-05-20 | ノボ・ノルデイスク・エー／エス | アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン |
| US8710000B2 (en) * | 2007-11-08 | 2014-04-29 | Novo Nordisk A/S | Insulin derivative |
| EP2254905B1 (en) | 2008-03-14 | 2016-12-14 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| EP2910570B1 (en) * | 2008-03-18 | 2016-10-12 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
| US9603904B2 (en) * | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
| KR20130092972A (ko) * | 2010-05-10 | 2013-08-21 | 노보 노르디스크 에이/에스 | 인슐린-아연 복합체의 제조 방법 |
| JP5931857B2 (ja) * | 2010-06-23 | 2016-06-08 | ノヴォ ノルディスク アー／エス | 追加のジスルフィド結合を含有するインスリン誘導体 |
| CN102947331B (zh) * | 2010-06-23 | 2016-08-03 | 诺沃—诺迪斯克有限公司 | 包含额外的二硫键的胰岛素类似物 |
| WO2012055967A2 (en) * | 2010-10-27 | 2012-05-03 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections administered with varying injection intervals |
| ES2594303T3 (es) | 2012-04-11 | 2016-12-19 | Novo Nordisk A/S | Formulaciones de insulina |
-
2014
- 2014-10-03 MX MX2016004325A patent/MX366636B/es active IP Right Grant
- 2014-10-03 HU HUE14780512A patent/HUE036702T2/hu unknown
- 2014-10-03 AU AU2014333979A patent/AU2014333979B2/en not_active Ceased
- 2014-10-03 DK DK14780512.1T patent/DK3055325T3/en active
- 2014-10-03 CN CN201480055375.6A patent/CN105636979B/zh not_active Expired - Fee Related
- 2014-10-03 KR KR1020167010201A patent/KR20160065126A/ko not_active Application Discontinuation
- 2014-10-03 WO PCT/EP2014/071236 patent/WO2015052088A1/en active Application Filing
- 2014-10-03 US US15/023,872 patent/US9896496B2/en not_active Expired - Fee Related
- 2014-10-03 CA CA2926701A patent/CA2926701A1/en not_active Withdrawn
- 2014-10-03 RU RU2016114098A patent/RU2673185C2/ru not_active IP Right Cessation
- 2014-10-03 RS RS20180322A patent/RS57004B1/sr unknown
- 2014-10-03 BR BR112016007166A patent/BR112016007166A2/pt not_active IP Right Cessation
- 2014-10-03 PT PT147805121T patent/PT3055325T/pt unknown
- 2014-10-03 SI SI201430644T patent/SI3055325T1/en unknown
- 2014-10-03 JP JP2016546167A patent/JP6499184B2/ja not_active Expired - Fee Related
- 2014-10-03 ES ES14780512.1T patent/ES2676065T3/es active Active
- 2014-10-03 EP EP14780512.1A patent/EP3055325B1/en not_active Not-in-force
- 2014-10-03 PL PL14780512T patent/PL3055325T3/pl unknown
-
2016
- 2016-03-08 IL IL244507A patent/IL244507B/en not_active IP Right Cessation
- 2016-04-07 SA SA516370893A patent/SA516370893B1/ar unknown
-
2018
- 2018-03-20 HR HRP20180468TT patent/HRP20180468T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE036702T2 (hu) | 2018-07-30 |
| EP3055325B1 (en) | 2018-01-03 |
| MX366636B (es) | 2019-07-17 |
| JP2017502074A (ja) | 2017-01-19 |
| EP3055325A1 (en) | 2016-08-17 |
| ES2676065T3 (es) | 2018-07-16 |
| SI3055325T1 (en) | 2018-05-31 |
| SA516370893B1 (ar) | 2018-08-13 |
| PT3055325T (pt) | 2018-04-06 |
| MX2016004325A (es) | 2016-07-11 |
| KR20160065126A (ko) | 2016-06-08 |
| CN105636979B (zh) | 2020-01-10 |
| AU2014333979A1 (en) | 2016-03-24 |
| US20160215037A1 (en) | 2016-07-28 |
| CA2926701A1 (en) | 2015-04-16 |
| RS57004B1 (sr) | 2018-05-31 |
| PL3055325T3 (pl) | 2018-06-29 |
| CN105636979A (zh) | 2016-06-01 |
| BR112016007166A2 (pt) | 2017-09-12 |
| IL244507A0 (en) | 2016-04-21 |
| US9896496B2 (en) | 2018-02-20 |
| RU2673185C2 (ru) | 2018-11-22 |
| AU2014333979B2 (en) | 2018-02-15 |
| IL244507B (en) | 2018-05-31 |
| JP6499184B2 (ja) | 2019-04-10 |
| RU2016114098A3 (ru) | 2018-05-21 |
| HRP20180468T1 (hr) | 2018-05-04 |
| WO2015052088A1 (en) | 2015-04-16 |
| DK3055325T3 (en) | 2018-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016114098A (ru) | Новое производное аналога инсулина | |
| JP2017502074A5 (ru) | ||
| JP2011241213A5 (ru) | ||
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
| EA201690069A1 (ru) | Применение высоких доз придопидина для лечения болезни хантингтона | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| EA201791333A1 (ru) | Производные глюкагона с улучшенной стабильностью | |
| WO2015128403A3 (en) | An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue | |
| MX2020010300A (es) | Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas. | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| PH12019501363A1 (en) | Insulin containing pharmaceutical compositions | |
| RU2013150861A (ru) | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| RU2018125622A (ru) | Способ применения карримицина против резистетности инфекции, спровоцированной микобактерией туберкулеза | |
| WO2014160155A3 (en) | Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof | |
| WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
| WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
| GB2607449B (en) | Activated insulin, compound Momordica charantia peptide oral medicine for treatment of diabetes, and preparation method | |
| MY170991A (en) | Dosing regimens of celgosivir for the treatment of dengue | |
| EA201101036A1 (ru) | Применение хлорида аммония в терапии | |
| JP2019535830A5 (ru) | ||
| MX2018011293A (es) | Composicion farmaceutica de liberacion prolongada que comprende cisteamina o sal de la misma. | |
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201004 |